PYRIMIDINE-2,4,6-TRIONES FOR USE IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
申请人:Cambria Pharmaceuticals, Inc.
公开号:EP2427438B1
公开(公告)日:2016-10-12
US9499494B2
申请人:——
公开号:US9499494B2
公开(公告)日:2016-11-22
[EN] PYRIMIDINE-2,4,6-TRIONES FOR USE IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS<br/>[FR] PYRIMIDINE-2,4,6-TRIONES DESTINÉE À ÊTRE UTILISÉE POUR LE TRAITEMENT D'UNE SCLÉROSE LATÉRALE AMYOTROPHE
申请人:CAMBRIA PHARMACEUTICALS INC
公开号:WO2010129665A2
公开(公告)日:2010-11-11
The present invention relates to the identification of inventive pyrimidine-2,4,6- triones (PYT compounds) and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The invention also provides methods of preparing the inventive PYT compounds.